Memorial Sloan Kettering Cancer Center

@MSKCancerCenter

Where you’re treated first, matters. To make an appointment: 877-871-9362

New York, New York

mskcc.org/news

Joined March 2009

Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Aug 17
New research from MSK uncovers why some leukemia patients stop responding to new drugs; examines how bone’s hardness shapes the immune battle against metastasis; shows how a telehealth tobacco treatment program helps cancer patients quit smoking; and more: bit.ly/3U61gGA
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Aug 14
🚨 Bad News for Cancer: Hear from MSK cancer biologist Dr. Scott Lowe and MSK senior scientist Dr. Aveline Filliol as they share research about an early stage #CART cell technique designed to target a cell surface protein called #uPAR that shrank solid tumors in laboratory
00:00
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Aug 10
The @US_FDA has expanded approval of Pluvicto® (¹⁷⁷Lu-PSMA-617) as an initial treatment for people with metastatic prostate cancer whose tumors are positive for the PSMA protein. The approval is based on results from the phase 3 PSMAddition trial, led in the U.S. by MSK
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Aug 7
(1/2) MSK researchers have identified ZFP36L2, a protein that connects the gut’s damage-sensing system to the ability of cells to change identities and repair an injury. The study, published in @Nature, was led by @KarunaMDPhD and @Qingwen_J. bit.ly/3RR5ukL
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Aug 6
Inherited #BRCA1 and #BRCA2 mutations may affect how breast tumors evolve and respond to treatment, according to a study from MSK and collaborators involving genomic data from more than 5,800 patients. MSK breast medical oncologist @PedramRazaviMD spoke with @TargetedOnc about